跳至主要内容
临床试验/NCT03968484
NCT03968484撤回不适用

Platelet Transfusion in Sepsis Trial (PlaTiSep)

University Hospital Tuebingen0 个研究点开始时间: 2020年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Overall survival in 90 day follow-up period

研究概览

简要总结

Platelets are important mediators of an inflammatory response and a key component of the innate immune system to defend the human body against invading pathogens. However, little evidence exists regarding the number of platelets that should be used als transfusion threshold in septic patients. In this trial platelet transfusion will be performed with either <50000/µl or <20000/µl as a trigger.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sepsis defined as alteration of SOFA score (Sepsis-related organ failure assessment score) >2 points (Sepsis-3 definition)
  • platelet count <50.000/µl

排除标准

  • Age less than 18 years
  • patients with immune thrombocytopenia
  • major bleeding in the last 72 hours or ongoing major bleeding
  • patient, surrogate or physician not committed to full intensive care support
  • pregnancy

结局指标

主要结局

Overall survival in 90 day follow-up period

时间窗: 90 days

overall survival at 90 days

次要结局

  • all cause mortality at 6 months(6 months)
  • duration of mechanical ventilation support(28 days)
  • resolution of shock(5 days)
  • ICU length of stay(28 days)
  • renal replacement therapy(28 days)
  • bleeding events(28 days)
  • SOFA score(28 days)
  • discharge location(90 days)

研究者

申办方类型
Other
责任方
Sponsor

相似试验